Acurx Pharmaceuticals, Inc. (ACXP) Earnings Call Transcripts
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. (ACXP) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 17 calls on record spanning November 14, 2022 to August 14, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 17 Acurx Pharmaceuticals, Inc. earnings call transcripts on record, spanning November 14, 2022 to August 14, 2026. Based on this history, Acurx Pharmaceuticals, Inc. reports quarterly. The most recent call on file is dated August 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ACXP
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 17
- First call
- November 14, 2022
- Most recent
- August 14, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 14, 2026 | Read transcript → |
| Q1 FY2026 | May 12, 2026 | Read transcript → |
| Q4 FY2025 | Mar 13, 2026 | Read transcript → |
| Q3 FY2025 | Nov 12, 2025 | Read transcript → |
| Q2 FY2025 | Aug 12, 2025 | Read transcript → |
| Q1 FY2025 | May 13, 2025 | Read transcript → |
| Q4 FY2024 | Mar 18, 2025 | Read transcript → |
| Q3 FY2024 | Nov 13, 2024 | Read transcript → |
| Q2 FY2024 | Aug 9, 2024 | Read transcript → |
| Q1 FY2024 | May 15, 2024 | Read transcript → |
| Q4 FY2023 | Mar 18, 2024 | Read transcript → |
| Company Conference Presentations | Jan 11, 2024 | Read transcript → |
| Q3 FY2023 | Nov 14, 2023 | Read transcript → |
| Q2 FY2023 | Aug 14, 2023 | Read transcript → |
| Q1 FY2023 | May 12, 2023 | Read transcript → |
| Q4 FY2022 | Mar 16, 2023 | Read transcript → |
| Q3 FY2022 | Nov 14, 2022 | Read transcript → |